<DOC>
	<DOCNO>NCT01497639</DOCNO>
	<brief_summary>The aim study compare efficacy safety profile newly introduce interleave stimulation mode standard double monopolar stimulation mode pallidal deep brain stimulation primary generalize segmental dystonia .</brief_summary>
	<brief_title>Comparison Efficacy Double Monopolar Versus Interleaving Stimulation Modes Pallidal Deep Brain Stimulation</brief_title>
	<detailed_description>Background : For treatment drug-refractory dystonia , bilateral pallidal deep brain stimulation ( GPi-DBS ) proven efficient option . On average , 40-55 % improvement dystonia rating scale ( DRS ) could achieve accord result multicenter trial last year . However , considerable portion ( 10-25 % ) patient experience minimal alleviation despite good electrode placement . These patient regard non-responders GPi-DBS define either limited improvement ( &lt; 25 % DRS ) worsen . Besides adjust amplitude , frequency pulse-width stimulation , one change electrode configuration commonly apply single monopolar stimulation mode ( one contact electrode negative ) either double monopolar stimulation ( two -usually adjacent- negative contact electrode stimulate amplitude pulse-width value ) bipolar stimulation mode ( one contact electrode positive ) case unsatisfactory outcome . Although technique utilized multicenter trial , non-responsiveness GPi-DBS occur . Recently investigator report Movement Disorders newly introduce interleave stimulation mode superior single double monopolar stimulation four patient initially ( 6-12 month implantation ) limit response GPi DBS . Aims study : To systematically compare efficacy side-effect profile double monopolar stimulation mode interleave stimulation mode prospective , randomize , double-blind , cross-over study . Methods : The investigator would enroll 20-25 patient drug refractory segmental generalize primary dystonia undergo bilateral GPi-DBS implantation within 2-3 year time frame . The inclusion exclusion criterion would follow study Kupsch et al .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>age 7 75 year mark disability owe primary generalized segmental dystonia , despite optimal pharmacologic treatment disease duration least 5 year . previous brain surgery ; cognitive impairment ( &lt; 120 point Mattis Dementia Rating Scale ) moderatetosevere depression ( &gt; 25 point Beck Depression Inventory ) mark brain atrophy detect magnetic resonance image medical psychiatric coexisting disorder could increase surgical risk interfere completion trial</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dystonia</keyword>
	<keyword>pallidal stimulation</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>deep brain stimulation GPi</keyword>
	<keyword>GPi</keyword>
	<keyword>interleave stimulation</keyword>
</DOC>